Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation

Thomas Schroeder, MD, Julia Fröbel, Ron Patrick Cadeddu, Akos G. Czibere, MD, Ariane Dienst, Esther Zipperer, MD, Uwe Platzbecker, MD, Gesine Bug, Lutz Uharek, MD, Roland Fenk, MD, Ulrich Germing, Nicolaus Kröger, Rainer Haas, MD, Guido Kobbe, MD

Blood (2012) 120 (21): 1964.

https://doi.org/10.1182/blood.V120.21.1964.1964

Published: 2012

Journal Articles

Safety and Efficacy of a Six Month Full Dose Lenalidomide Consolidation Treatment After First-Line High-Dose Therapy in Patients with Multiple Myeloma

Roland Fenk, MD, Julia Baier, Aristoteles Giagounidis, MD, Mathias J. Rummel, MD, Nicolaus Kröger, Tobias Strapatsas, MD, Ariane Dienst, Esther Zipperer, MD, Kathrin Nachtkamp, MD, Alexander Burchardt, MD, Thomas Schroeder, MD, Lars Galonska, MD, Norbert Gattermann, MD, Rainer Haas, MD, Guido Kobbe, MD

Blood (2012) 120 (21): 1982.

https://doi.org/10.1182/blood.V120.21.1982.1982

Published: 2012

Journal Articles

Outcome of Refractory Anemia with Ringed Sideroblasts Associated with Marked Thrombocytosis (RARS-T) In a Large Cohort of Patients

Blood (2010) 116 (21): 4113.

https://doi.org/10.1182/blood.V116.21.4113.4113

Published: 2010

Journal Articles

Myelodysplastic Syndrome (MDS)-Specific Comorbidity Index for Predicting the Impact of Extra-Hematological Comorbidities on Survival of Patients with MDS

Matteo G Della Porta, MD, Andrea Kuendgen, MD, Luca Malcovati, MD, Esther Zipperer, MD, Cristiana Pascutto, PhD, Erica Travaglino, Margherita Maffioli, MD, Ilaria Ambaglio, MD, Rosangela Invernizzi, MD, Ulrich Germing, MD, Mario Cazzola, MD

Blood (2008) 112 (11): 2677.

https://doi.org/10.1182/blood.V112.11.2677.2677

Published: 2008

Journal Articles

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 10 9 /L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

Norbert Gattermann, Johan Billiet, Ralf Kronenwett, Esther Zipperer, Ulrich Germing, Friedel Nollet, Arnold Criel, Dominik Selleslag

Blood (2007) 109 (3): 1334–1335.

https://doi.org/10.1182/blood-2006-05-022491

Published: 2007

NARROW

Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation

Safety and Efficacy of a Six Month Full Dose Lenalidomide Consolidation Treatment After First-Line High-Dose Therapy in Patients with Multiple Myeloma

Outcome of Refractory Anemia with Ringed Sideroblasts Associated with Marked Thrombocytosis (RARS-T) In a Large Cohort of Patients

Myelodysplastic Syndrome (MDS)-Specific Comorbidity Index for Predicting the Impact of Extra-Hematological Comorbidities on Survival of Patients with MDS

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 10 9 /L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

Email alerts

ASH Publications

American Society of Hematology

Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation

Safety and Efficacy of a Six Month Full Dose Lenalidomide Consolidation Treatment After First-Line High-Dose Therapy in Patients with Multiple Myeloma

Outcome of Refractory Anemia with Ringed Sideroblasts Associated with Marked Thrombocytosis (RARS-T) In a Large Cohort of Patients

Myelodysplastic Syndrome (MDS)-Specific Comorbidity Index for Predicting the Impact of Extra-Hematological Comorbidities on Survival of Patients with MDS

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 10 9 /L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only